TY - JOUR
T1 - Integrating patients’ perceptions into clinical practice guidelines for the management of rheumatoid arthritis in Japan
AU - Kojima, Masayo
AU - Nakayama, Takeo
AU - Otani, Takashi
AU - Hasegawa, Mieko
AU - Kawahito, Yutaka
AU - Kaneko, Yuko
AU - Kishimoto, Mitsumasa
AU - Hirata, Shintaro
AU - Seto, Yohei
AU - Endo, Hirahito
AU - Ito, Hiromu
AU - Kojima, Toshihisa
AU - Nishida, Keiichiro
AU - Matsushita, Isao
AU - Tsutani, Kiichiro
AU - Igarashi, Ataru
AU - Kamatani, Naoyuki
AU - Miyasaka, Nobuyuki
AU - Yamanaka, Hisashi
N1 - Funding Information:
This work was supported by Health and Labour Sciences Research Grants for Research on Rare and Intractable Diseases [grant number H26-Meneki-Shitei-021] and a grant from the Japan Society for the Promotion of Science, JSPS KAKENHI [grant numbers JP21590708, JP26460608].
Publisher Copyright:
© 2017 Japan College of Rheumatology.
PY - 2017/11/2
Y1 - 2017/11/2
N2 - Objective: Patients’ values and preferences are among the key factors that determine the strength of recommendations presented in clinical practice guidelines (CPG). The aim of this study was to summarize the integration process for patients’ perceptions into the development of CPG for rheumatoid arthritis (RA) management in Japan. Methods: We used a mixed-methods approach. Questionnaires that could be self-administered were mailed to 2222 RA patients randomly selected from the Japan Rheumatism Friendship Association (JRFA) membership list that was age- and prefecture-stratified. A focus group with five JRFA executive members was formed to verify the results of the questionnaire. Results: A total of 1470 patients aged 20–79 years old returned the questionnaire. Analysis of the questionnaire data revealed that the topics selected by the CPG task force met the patients’ needs. The focus group participants showed reluctance to use the term ‘preference’ because patients would not want to take any medications but would have to take them out of necessity. Conclusions: We confirmed that the new CPG successfully addressed clinical issues that were important to both rheumatologists and patients. Clinicians should understand patients’ reluctance to take medications and explain the role of each medication well to increase adherence.
AB - Objective: Patients’ values and preferences are among the key factors that determine the strength of recommendations presented in clinical practice guidelines (CPG). The aim of this study was to summarize the integration process for patients’ perceptions into the development of CPG for rheumatoid arthritis (RA) management in Japan. Methods: We used a mixed-methods approach. Questionnaires that could be self-administered were mailed to 2222 RA patients randomly selected from the Japan Rheumatism Friendship Association (JRFA) membership list that was age- and prefecture-stratified. A focus group with five JRFA executive members was formed to verify the results of the questionnaire. Results: A total of 1470 patients aged 20–79 years old returned the questionnaire. Analysis of the questionnaire data revealed that the topics selected by the CPG task force met the patients’ needs. The focus group participants showed reluctance to use the term ‘preference’ because patients would not want to take any medications but would have to take them out of necessity. Conclusions: We confirmed that the new CPG successfully addressed clinical issues that were important to both rheumatologists and patients. Clinicians should understand patients’ reluctance to take medications and explain the role of each medication well to increase adherence.
KW - Rheumatoid arthritis
KW - clinical practice guidelines
KW - focus group
KW - patients’ perspectives
KW - questionnaire survey
UR - http://www.scopus.com/inward/record.url?scp=85010699635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85010699635&partnerID=8YFLogxK
U2 - 10.1080/14397595.2016.1276511
DO - 10.1080/14397595.2016.1276511
M3 - Article
C2 - 28121192
AN - SCOPUS:85010699635
SN - 1439-7595
VL - 27
SP - 924
EP - 929
JO - Japanese Journal of Rheumatology
JF - Japanese Journal of Rheumatology
IS - 6
ER -